These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 11351263

  • 1. Synergistic effect of photodynamic therapy with hypericin in combination with hyperthermia on loss of clonogenicity of RIF-1 cells.
    Chen B, Xu Y, Agostinis P, De Witte PA.
    Int J Oncol; 2001 Jun; 18(6):1279-85. PubMed ID: 11351263
    [Abstract] [Full Text] [Related]

  • 2. Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model.
    Chen B, Roskams T, Xu Y, Agostinis P, de Witte PA.
    Int J Cancer; 2002 Mar 10; 98(2):284-90. PubMed ID: 11857421
    [Abstract] [Full Text] [Related]

  • 3. Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia.
    Chen B, Roskams T, de Witte PA.
    Lasers Surg Med; 2002 Mar 10; 31(3):158-63. PubMed ID: 12224088
    [Abstract] [Full Text] [Related]

  • 4. Photoactivation of hypericin down-regulates glutathione S-transferase activity in nasopharyngeal cancer cells.
    Du HY, Olivo M, Tan BK, Bay BH.
    Cancer Lett; 2004 Apr 30; 207(2):175-81. PubMed ID: 15072826
    [Abstract] [Full Text] [Related]

  • 5. Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy.
    Chen B, Zupkó I, de Witte PA.
    Int J Oncol; 2001 Apr 30; 18(4):737-42. PubMed ID: 11251168
    [Abstract] [Full Text] [Related]

  • 6. Pre-treatment of HT-29 cells with 5-LOX inhibitor (MK-886) induces changes in cell cycle and increases apoptosis after photodynamic therapy with hypericin.
    Kleban J, Szilárdiová B, Mikes J, Horváth V, Sacková V, Brezáni P, Hofmanová J, Kozubík A, Fedorocko P.
    J Photochem Photobiol B; 2006 Aug 01; 84(2):79-88. PubMed ID: 16545574
    [Abstract] [Full Text] [Related]

  • 7. Hypericin in cancer treatment: more light on the way.
    Agostinis P, Vantieghem A, Merlevede W, de Witte PA.
    Int J Biochem Cell Biol; 2002 Mar 01; 34(3):221-41. PubMed ID: 11849990
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms involved in the cell cycle and apoptosis of HT-29 cells pre-treated with MK-886 prior to photodynamic therapy with hypericin.
    Kleban J, Mikes J, Horváth V, Sacková V, Hofmanová J, Kozubík A, Fedorocko P.
    J Photochem Photobiol B; 2008 Nov 13; 93(2):108-18. PubMed ID: 18771933
    [Abstract] [Full Text] [Related]

  • 9. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
    Bhuvaneswari R, Gan YY, Yee KK, Soo KC, Olivo M.
    Int J Mol Med; 2007 Oct 13; 20(4):421-8. PubMed ID: 17786271
    [Abstract] [Full Text] [Related]

  • 10. Antivascular tumor eradication by hypericin-mediated photodynamic therapy.
    Chen B, Roskams T, de Witte PA.
    Photochem Photobiol; 2002 Nov 13; 76(5):509-13. PubMed ID: 12462645
    [Abstract] [Full Text] [Related]

  • 11. Potentiation of photodynamic therapy with hypericin by mitomycin C in the radiation-induced fibrosarcoma-1 mouse tumor model.
    Chen B, Ahmed B, Landuyt W, Ni Y, Gaspar R, Roskams T, de Witte PA.
    Photochem Photobiol; 2003 Sep 13; 78(3):278-82. PubMed ID: 14556315
    [Abstract] [Full Text] [Related]

  • 12. Histomorphological changes in murine fibrosarcoma after hypericin-based photodynamic therapy.
    Bobrov N, Cavarga I, Longauer F, Rybárová S, Fedorocko P, Brezáni P, Miskovský P, Mirossay L, Stubna J.
    Phytomedicine; 2007 Feb 13; 14(2-3):172-8. PubMed ID: 17095201
    [Abstract] [Full Text] [Related]

  • 13. Photodynamic-induced apoptosis of human nasopharyngeal carcinoma cells using Hypocrellins.
    Ali SM, Olivo M, Yuen GY, Chee SK.
    Int J Oncol; 2001 Sep 13; 19(3):633-43. PubMed ID: 11494047
    [Abstract] [Full Text] [Related]

  • 14. The multifaceted photocytotoxic profile of hypericin.
    Theodossiou TA, Hothersall JS, De Witte PA, Pantos A, Agostinis P.
    Mol Pharm; 2009 Sep 13; 6(6):1775-89. PubMed ID: 19739671
    [Abstract] [Full Text] [Related]

  • 15. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
    Du HY, Bay BH, Olivo M.
    Int J Oncol; 2003 May 13; 22(5):1019-24. PubMed ID: 12684667
    [Abstract] [Full Text] [Related]

  • 16. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
    Zupkó I, Kamuhabwa AR, D'Hallewin MA, Baert L, De Witte PA.
    Int J Oncol; 2001 May 13; 18(5):1099-105. PubMed ID: 11295062
    [Abstract] [Full Text] [Related]

  • 17. Hypericin and its radio iodinated derivatives - A novel combined approach for the treatment of pediatric alveolar rhabdomyosarcoma cells in vitro.
    Ocker L, Adamus A, Hempfling L, Wagner B, Vahdad R, Verburg FA, Luster M, Schurrat T, Bier D, Frank M, Lisec J, Engel N, Seitz G.
    Photodiagnosis Photodyn Ther; 2020 Mar 13; 29():101588. PubMed ID: 31704507
    [Abstract] [Full Text] [Related]

  • 18. Comparison of hexamethylhypericin and tetrabromohypericin to hypericin for their in vivo efficacy as PDT tools.
    Delaey E, Zupko I, Chen B, Derycke A, van Laar F, De Vos D, De Witte P.
    Int J Oncol; 2003 Aug 13; 23(2):519-24. PubMed ID: 12851704
    [Abstract] [Full Text] [Related]

  • 19. Hypericin-mediated photodynamic therapy inhibits growth of colorectal cancer cells via inducing S phase cell cycle arrest and apoptosis.
    Hu J, Song J, Tang Z, Wei S, Chen L, Zhou R.
    Eur J Pharmacol; 2021 Jun 05; 900():174071. PubMed ID: 33811836
    [Abstract] [Full Text] [Related]

  • 20. Conjunction of glutathione level, NAD(P)H/FAD redox status and hypericin content as a potential factor affecting colon cancer cell resistance to photodynamic therapy with hypericin.
    Mikešová L, Mikeš J, Kovaľ J, Gyurászová K, Culka L, Vargová J, Valeková B, Fedoročko P.
    Photodiagnosis Photodyn Ther; 2013 Dec 05; 10(4):470-83. PubMed ID: 24284100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.